Why the study?
Does cardiac-restricted overexpression of Bcl-2 prevent adverse cardiac remodeling and cardiomyocyte apoptosis in transgenic mice with cardiac-restricted overexpression of TNF?
Does cardiac-restricted overexpression of Bcl-2 prevent adverse cardiac remodeling and cardiomyocyte apoptosis in transgenic mice with cardiac-restricted overexpression of TNF?
Sustained TNF-induced inflammation activates multiple cell death pathways in cardiomyocytes, and blocking the intrinsic pathway alone with Bcl-2 is insufficient to fully prevent apoptosis, highlighting the complexity of adverse cardiac remodeling.
Answers are grounded in this paper and cite their sources.
Bcl-2 overexpression alone insufficient to block TNF-driven apoptosis in mice; hypothesis-generating for multi-pathway targeting in inflammatory cardiomyopathy.
Transgenic mice with cardiac-restricted overexpression of secretable TNF (MHCsTNF) develop progressive LV wall thinning and dilation accompanied by an increase in cardiomyocyte apoptosis and a progressive loss of cytoprotective Bcl-2. To test whether cardiac-restricted overexpression of Bcl-2 would prevent adverse cardiac remodeling, we crossed MHCsTNF mice with transgenic mice harboring cardiac-restricted overexpression of Bcl-2. Sustained TNF signaling resulted in activation of the intrinsic cell death pathway, leading to increased cytosolic levels of cytochrome c, Smac/Diablo and Omi/HtrA2, and activation of caspases -3 and -9. Cardiac-restricted overexpression of Bcl-2 blunted activation of the intrinsic pathway and prevented LV wall thinning; however, Bcl-2 only partially attenuated cardiomyocyte apoptosis. Subsequent studies showed that c-FLIP was degraded, that caspase-8 was activated, and that Bid was cleaved to t-Bid, suggesting that the extrinsic pathway was activated concurrently in MHCsTNF hearts. As expected, cardiac Bcl-2 overexpression had no effect on extrinsic signaling. Thus, our results suggest that sustained inflammation leads to activation of multiple cell death pathways that contribute to progressive cardiomyocyte apoptosis; hence the extent of such programmed myocyte cell death is a critical determinant of adverse cardiac remodeling.
No takes yet. Share an insight, caveat, or question.
Haudek et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: